FST FY 2025 Annual ReportBeta
FST annual report for FY 2025, filed with DART (Korea Financial Supervisory Service) on March 18, 2026. This page provides AI-powered English analysis including business overview, management discussion & analysis (MD&A), risk factors, and KIFRS consolidated financial data such as revenue, net income, gross margin, operating margin, and return on equity (ROE).
FST FY 2025 Annual Report Analysis
Business Overview
- • Pellicle and chiller semiconductor material/equipment revenue KRW 2.8T (FY2025), with materials at KRW 1.663T (59%), equipment KRW 1.114T (40%)
- • EUV pellicle and related equipment development ongoing; customer qualification expected by Dec 2025; first demo sales in 2023 completed
Management Discussion & Analysis
- • Revenue KRW 28.0B (+18.1% YoY), operating loss KRW 54.7M (vs. KRW 2.29B profit), net loss KRW 14.33B (+753.2% YoY)
- • Pellicle segment revenue KRW 11.07B (+14% YoY) driven by expanded DUV pellicle sales; materials segment revenue KRW 16.63B (+35% YoY) from new customers
Risk Factors
- • KRW 97.1M sensitivity to 1% USD/KRW exchange rate rise on FX exposure impacting net income
- • KRW 28.8B foreign currency monetary assets vs KRW 4.67B liabilities at fiscal year-end, mainly USD, JPY, CNY
FST FY 2025 Key Financial MetricsDART
Total Assets
KRW 540.1B
▲ +6.7% YoY
Operating Cash Flow
KRW 14.1B
▲ +361.3% YoY
CapEx
KRW 48.3B
▼ -29.5% YoY
Source: KIFRS consolidated financial data from FST annual report on DART. All figures in KRW.
Source: DART (Korea Financial Supervisory Service) · AI summaries generated from the original Korean filing (English output) · Beta: coverage is expanding